seller, page-3

Two major brokers were moving a line of stock yesterday on behalf of a large client who was sitting on a big profit and of course as is the case for all of us shareholders in Acrux its taxfree!!
On Monday Baillieu hosted a broker presentation by Richard Treagus the M.D.of Acrux. My contact said presentation was compelling particularly with the advantage Axiron (their testosterone replacement) has over its competitors. Apparently Treagus is most impressive and the company are moving(as they have previously reported) in a very deliberate measured manner towards a successful partnering programme with Axirion in particular which has the potential to attract considerable interest and capital from major overseas pharmaceutical giants.